| Date | Title | Description |
| 27.07.2026 | Nano Dimension’s $890 Million AI Healthcare Pivot Now Hangs in the Balance | Last month, Israeli 3D printer manufacturer Nano Dimension signed a non-binding term sheet to merge with Infinite Epigenetics, an AI-powered preventive health and diagnostics company, in a proposed deal valued at $890 million. If completed,... |
| 09.06.2026 | The perfect spot for a farm? Vacant office buildings in downtown Chicago. | Getting your Trinity Audio player ready...
Imagine walking into one of the towering buildings in the Chicago Loop.
You ride the elevator up a dozen floors. When the doors open, a faint earthy smell greets you. Stepping off the elevator, ins... |
| 28.05.2026 | Median Technologies: €40 Million Capital Increase Launched To Support eyonis LCS Expansion | Median Technologies announced the launch of a €40 million capital increase, with the potential to increase to €50 million, to support the commercial deployment of its AI-powered eyonis LCS lung cancer screening platform in the United States... |
| 25.03.2026 | In AI and in health | - |
| 09.03.2026 | Healthcare AI pilots outpace sector's regulatory readiness | - |
| 19.02.2026 | This AI-powered health tech stock is undervalued and poised for big gains, says Mizuho | - |
| 21.01.2026 | BIOMAKERS Raises Additional $8 Million To Scale Global Precision Oncology Intelligence Platform | BIOMAKERS, a San Francisco-headquartered precision medicine and oncology intelligence company, announced it has closed an additional $8 million in financing as it shifts from building diagnostics and data infrastructure to scaling an AI-nat... |
| 20.01.2026 | Another alliance of health care and AI signals why pharma stocks should be back in favor | - |
| 29.12.2025 | AHN Cancer Institute Accelerates Access to Cutting-Edge Therapies Through Tempus TIME Trial Program | Utilization of Tempus' TIME program streamlines clinical trial matching and activation using artificial intelligence, bringing innovative treatments to patients faster
PITTSBURGH, Dec. 29, 2025 /PRNewswire-PRWeb/ -- Allegheny Health Network... |
| 19.12.2025 | The rise and impact of AI in Biotechnology and Healthcare | - |
| 17.12.2025 | Bioptimus Unveils M-Optimus, a World Model for Biology | Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation
The Unveiling of M-Optimus: Bioptimus has trained its inaugural World Model fo... |
| 15.12.2025 | The AI Paradox: Why Some Tools Save Millions While Others Increase Physician Burnout | Sanket Patel. co-founder of Digicorp Health
AI has become everyone’s favourite topic in healthcare. From predicting diseases to creating personalised treatment plans, it’s already changing how hospitals, insurers, and health tech companies ... |
| 12.11.2025 | Laboratory Economics Issues Research Report on U.S. Anatomic Pathology Market | Laboratory Economics has just published the most comprehensive and detailed market research report available on the U.S. Anatomic Pathology Market. This is an ideal resource for preparing business plans and market strategies.
POUGHKEEPSIE, ... |
| 05.11.2025 | SoftBank shares plunge 10%, wiping $23 billion in market cap, as AI stocks slide on valuation jitters | Shares of SoftBank fell more than 14%, while Advantest declined over 8%.
South Korean memory chip giants Samsung Electronics and SK Hynix lost nearly 6%.
Shares in Japan's SoftBank Group closed 10% lower on Wednesday, amid a broader drop in... |
| 20.10.2025 | Stocks making the biggest moves midday: Apple, Cleveland-Cliffs, Oracle, KLA, Tempus AI and more | - |
| 22.08.2025 | M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M | What You Should Know:
– Tempus AI, Inc., a technology company focused on advancing precision medicine with AI, has acquired Paige, an AI company specializing in digital pathology.
– The acquisition, valued at $81.25M, paid predominantly in ... |
| 11.08.2025 | Vertical AI: The Rise of Industry-Specific Intelligence Rather than the traditional view of India as a consumer of global AI solutions, there is a growing opportunity today to take the lead in creatin... | Artificial Intelligence is advancing at a very rapid pace, and among the most exciting frontiers is the arrival of Vertical AI industry ~ vertical intelligence for areas like healthcare, law, agriculture, manufacturing, and finance. As comp... |
| 05.08.2025 | iBIO Releases Inaugural Member Investor Portfolio Report Showcasing $1.24 Billion in Illinois Life Sciences Investment | Report highlights nearly 100 life science companies and investment trends as Chicago prepares to welcome BIO International Convention 2030
CHICAGO, Aug. 5, 2025 /PRNewswire-PRWeb/ -- The Illinois Biotechnology Innovation Organization (iBIO)... |
| 09.07.2025 |
Cramer’s Lightning Round: No to Ouster | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Insmed: ”...That one is very speculative. I... |
| 09.07.2025 | Personalis Expands Tempus AI Collaboration to Include Colorectal Cancer | What You Should Know:
– Personalis, Inc. announced a significant expansion and extension of its strategic collaboration with Tempus AI, Inc. that adds colorectal cancer (CRC) as a new indication to their existing, exclusive commercializatio... |
| 15.05.2025 | AI-powered drug development startup Pathos AI closes $365M investment
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide fre... | Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding.
The company didn’t disclose the investors in the Series D round. According to Fi... |
| 08.05.2025 | Tempus AI Stock: Time to Double Down or Cut and Run? Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside... |
[content-module:CompanyOverview|NASDAQ:TEM]
Tempus AI (NASDAQ: TEM) is an interesting AI story that operates a platform and library for diagnosis and drug discovery. The platform aids physicians by enabling personalized care for hard-to-tr... |
| 07.05.2025 | Is Nancy Pelosi’s latest stock bet a buy after earnings? | Summary
⚈ Tempus AI’s Q1 results saw 75.4% revenue growth and a $200 million AstraZeneca deal.
⚈ Despite a post-earnings dip, Tempus AI remains promising with raised guidance to $1.25B.
⚈ Pelosi’s call options on Tempus AI reflect long-term... |
| 01.05.2025 |
Cramer’s Lightning Round: BlackRock is a buy | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
BlackRock: “I think it should be bought. Th... |
| 12.03.2025 | Target's Grocery Expansion: A Recipe for Success | Target is cooking up something big. The retail giant is set to add 600 new items to its grocery lineup in 2025. This move is part of a larger strategy to boost sales by over $15 billion by 2030. The grocery sector is a battlefield, and Targ... |
| 10.03.2025 | Digital physical therapy provider Hinge Health files for IPO | Digital physical therapy startup Hinge Health filed its IPO prospectus with the SEC on Monday.
The company’s revenue jumped 33% in 2024 to $390 million.
Hinge Health uses software to help patients treat musculoskeletal injuries and chronic ... |
| 06.03.2025 | Inside the Meta Machine: A Candid Look at the Social Media Giant | The world of social media is a double-edged sword. It connects us, yet it can also divide us. A new memoir promises to peel back the layers of one of the most influential companies in this space: Meta. “Careless People,” written by Sarah Wy... |
| 06.03.2025 | Ataraxis AI Raises $20.4M in Series A Funding | Ataraxis AI, a NYC-based AI precision medicine company, raised $20.4M in Series A funding.
The round was led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, and existing investors, ... |
| 26.02.2025 | Tempus AI Is a Buy, If You Can Handle the Volatility Tempus AI is well-positioned to capitalize on its extensive clinical data database. It can provide personalized treatment for hard-to-treat illness... |
[content-module:CompanyOverview|NASDAQ:TEM]
Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook for long-term growth and profitability. The company uses AI to manage patient testing and help physi... |
| 24.02.2025 | Stocks making the biggest moves after hours: Hims & Hers Health, Tempus AI, Diamondback Energy and more | - |
| 17.02.2025 | Conflicting Signals: Tempus AI's Stock Market Rally Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review. |
Tempus AI (NASDAQ: TEM) is a leader in precision medicine and artificial intelligence (AI) in the healthcare sector. Tempus AI’s stock price has seen an increase, with gains of over 160% in the last month and almost 150% year-to-date, caus... |
| 23.01.2025 | Tempus AI Launches AI-Powered Personal Health Concierge App | What You Should Know:
– Tempus AI, a provider of AI-powered precision medicine launches olivia, an innovative personal health concierge app designed to revolutionize how patients manage their health information.
– olivia brings together a p... |
| 22.01.2025 | Tempus AI: A Game-Changer in AI-Powered Healthcare TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the ... |
Shares of Tempus AI Inc. (NASDAQ: TEM) surged 35% on Tuesday, bringing its market capitalization to $7.5 billion. The rally was driven by headline-grabbing news and strong market sentiment, underscoring the company’s leadership in integrat... |
| 06.01.2025 | Зарубежные IPO 2024 года: какие компании стали публичными | В 2024 году на фондовом рынке США 193 компании провели первичное размещение своих акций. К 20 ноября объем IPO вырос на 34,03% по сравнению с аналогичным периодом 2023 года. 75% компаний, вышедших на биржу к июлю 2024 года, принесли акционе... |
| 03.01.2025 | DataLend: 2024 Securities Lending Revenue Down 10% YoY to $9.64 Billion | Lending revenue dips against backdrop of record-high indices
NEW YORK, Jan. 3, 2025 /PRNewswire/ -- The global securities finance industry generated $9.64 billion in revenue for lenders in 2024, according to DataLend, the market data servic... |
| 11.12.2024 | The AI Revolution: Transforming Healthcare and IT for a New Era | Artificial Intelligence (AI) is not just a buzzword; it’s a tidal wave reshaping industries. In healthcare and IT, AI is the engine driving efficiency, precision, and innovation. The transformation is profound, with each sector harnessing A... |
| 11.12.2024 | AI transforming healthcare with better outcomes & efficiency | The healthcare industry is experiencing significant changes driven by advancements in artificial intelligence (AI), which is altering how care is delivered and improving patient outcomes.
The global AI in healthcare market is on a growth pa... |
| 25.10.2024 | The Role of Illinois’s Tech Industry in Global Health Initiatives | Share
Tweet
Share
Share
Email
Illinois has emerged as a significant player in the global tech space, particularly in the field of health technology. With a rich tapestry of companies, startups, and research institutions, the state is levera... |
| 21.08.2024 | BerGenBio Second Quarter Results 2024: Solid clinical and financial progress | BerGenBio Second Quarter Results 2024: Solid clinical and financial progress
Wed, Aug 21, 2024 07:00 CET Report this content
Bergen, Norway, August 21, 2024 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing... |
| 20.08.2024 | BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer | BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer
Tue, Aug 20, 2024 07:00 CET Report this content
Bergen, Norway, August 20, 2024, – BerGenBio ASA (OSE: BGBIO), a clinical-stage bi... |
| 17.08.2024 | The AI Revolution in Healthcare: A New Era of Efficiency and Care | The healthcare landscape is undergoing a seismic shift. Artificial intelligence (AI) is not just a buzzword; it’s a game-changer. Companies like Stryker and Avant Technologies are leading the charge, transforming how care is delivered. The ... |
| 14.08.2024 | Examining the Role of AI in Advancing Healthcare Efficiency | USA News Group Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, Aug. 14, 2024 /PRNewswire/ -- USA News Group – A technological transformation is underway in healthcare, with providers and tech developers leaning into th... |
| 06.08.2024 | SoftBank seen posting modest profit in Q1, buyback potential in focus | TOKYO : Japan's SoftBank Group is expected to report a modest first-quarter profit on Wednesday but investors are set to hone in on whether the tech investment giant will either announce a major share buyback or flag its willingness to emba... |
| 31.07.2024 | Daniella Bellaire, Jim Geurts, and James Lyman join LMN's Executive Team | MARKHAM, ON, July 31, 2024 /PRNewswire/ - Landscape Management Network (LMN), the leading provider of business management software for the landscape industry, is pleased to announce the addition of three new executives to its leadership tea... |
| 17.07.2024 | US-based AI startups that raised over $100 million in funding in 2024 | ETtech
Venture capital investors cannot get enough of the growing artificial intelligence (AI) wave, with startups in the US roping in big funding in the first half of 2024. Even as Indian AI startups saw a dip in funding, those in the US d... |
| 08.07.2024 | Digital Health Funding Surges TO $5.7B in Early 2024 Despite Market Jitters, Rock Health Reports | What You Should Know:
– The digital health industry is showing signs of strength despite recent economic uncertainties, according to Rock Health’s latest H1 report.
– U.S. digital health startups raised a significant amount in the first hal... |
| 30.06.2024 | Automotive lifecycle data startup Solera files for IPO, seeking to raise $1.5B
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to pr... | Automotive data software startup Solera Corp. filed paperwork for an initial public offering with the U.S. Securities and and Exchange Commission on Friday, confirming an earlier report from Bloomberg that first revealed its IPO plans.
The ... |
| 27.06.2024 | Eye On AI: OpenAI Goes On A Buying Spree As AI Looks To Open Up M&A, IPO Markets | 11 Shares Email Facebook Twitter LinkedIn
This column is a look back at the week that was in AI. Read the previous one here.
It may be the big funding rounds that grab the headlines when it comes to the startup world, but for investors it’s... |
| 14.06.2024 | Ex-Groupon CEO raises $411 million in IPO for medicine data company | figcaption>span]:font-sans" data-chromatic="ignore">
Tempus AI, a Chicago-based provider of data and analytics tools for precision medicine developers, raised $411 million in its IPO.
Why it matters: You probably didn't... |
| 14.06.2024 | Tempus AI makes IPO debut, valuing the precision medicine startup at $6 billion | After years of anticipation, AI-driven precision medicine startup Tempus AI is finally making its debut on the U.S. market. Backed by heavyweights like Google and SoftBank Group, Tempus AI has set the price of its initial public offering (I... |
| 03.02.2024 | Tempus Launches AI Assistant ‘Tempus One’ for Enhanced Research in Lens Data Analytics Platform | Tempus, a leader in artificial intelligence and precision medicine, announced the integration of its signature Tempus One technology into its Lens data analytics platform. The AI-enabled Tempus One technology will leverage advancements in g... |
| 25.01.2024 | Tempus is an In-Network Provider for Humana, Expanding Access to its Next-Gen Sequencing Tests | Tempus, a leader in artificial intelligence and precision medicine, announced that the company has signed agreements for in-network provider status with Humana Inc. Under the agreement, Humana’s over 13 million members will have improved ac... |
| 22.01.2024 | Tempus Introduces xM to Assess MRD in Patients with CRC for Research Use Only | Data on xM presented at the 2024 ASCO Gastrointestinal Cancers Symposium
Tempus, a leader in artificial intelligence and precision medicine, announced the addition of a novel MRD assay, xM, to its comprehensive testing solutions. The tumor-... |
| 06.11.2023 | Tempus Announces New ctDNA Assay, xF Monitor | Tumor uninformed treatment response monitoring assay for research use only
Tempus, a leader in artificial intelligence and precision medicine, announced xF Monitor – a new circulating tumor DNA (ctDNA) assay for research use only, which det... |
| 12.07.2023 | Tempus Announces the GEMINI Non-Small Cell Lung Cancer Study | Study aims to create the most robust, multi-omic dataset for patients with NSCLC
Tempus, a leader in artificial intelligence and precision medicine, announces its GEMINI Non-small Cell Lung Cancer (NSCLC) study (NCT05236114). The Tempus-spo... |
| 10.07.2023 | Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics | Tempus, a leader in artificial intelligence and precision medicine announced a new collaboration to develop a companion diagnostic (CDx) test with TScan Therapeutics, a clinical-stage biopharmaceutical company focused on the development of ... |
| 02.06.2023 | Tempus Announces Broad Launch of Tempus One | AI-enabled clinical assistant provides access to patient insights directly at your fingertips
Tempus, a leader in artificial intelligence (AI) and precision medicine, announced the upcoming broad launch of Tempus One – the first, AI-enabled... |
| 03.05.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 3rd May 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| 02.05.2023 | Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device | xT CDx is the company’s first Premarket Approval from the FDA
Tempus, a leader in artificial intelligence and precision medicine, announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first Premarket Approval... |
| 02.03.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 02nd March 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| 01.03.2023 | Tempus Announces New Strategic Collaboration with Pfizer to Advance Oncology Therapeutic Development | Tempus, a leader in artificial intelligence (AI) and precision medicine, announced a multi-year, strategic collaboration with Pfizer in which the two companies are working together to further AI and machine learning-driven efforts in therap... |
| 23.02.2023 | Tempus Forms Multi-omics Collaboration With Actuate Therapeutics | What You Should Know:
– Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomi... |
| 02.02.2023 | The 15 billion-dollar healthcare startups facing a make-or-break year in 2023 | Roman This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Startup valuations are crashing in 2023 as the public market tumbles.
Billion-dollar healthcare startups could take a hit to their va... |
| 06.01.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 6th January 2023 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| 05.01.2023 | Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer | Tempus, a leader in artificial intelligence and precision medicine, announced a prospective study , in collaboration with AstraZeneca , that aims to identify biomarkers of response in patients with small cell lung cancer (SCLC). The study, ... |
| 10.11.2022 | Куда гоу: Insider составил список из 25 стартапов, оплачивающих рабочие визы для иностранцев | Не смотря на массовые увольнения в IT-компаниях, от которых ещё несколько месяцев назад никто ничего подобного не ожидал, есть стабильные бизнесы, которые продолжают нанимать сотрудников. Insider составил полезный список-напоминалку из 25 с... |
| 04.11.2022 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 4th November 2022 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| 03.11.2022 | Tempus Launches First Cardiology Prospective Study for Its AI-Enabled Predictive Tests | In collaboration with iRhythm, Tempus is studying its predictive, AI-enabled algorithmic tests via a network of researchers to determine the impact of detecting patients at increased risk of developing cardiovascular disease
Tempus, a leade... |
| 28.10.2022 | Tempus Launches Real-World Data-Driven Program to Accelerate Precision Oncology Research | What You Should Know: |
| 24.10.2022 | Digital health news, funding round up in the prior week; October 24, 2022 | Eli Lilly acquired Akouos; Tempus raised $275M; Calm launched Calm Health
Top Health News
Pfizer asked the Supreme Court to decide whether a proposed program to help Medicare patients pay out-of-pocket costs for its tafamidis drugs—Vyndaqel... |
| 18.10.2022 | GSK expands AI partnership with Tempus, fronting $70M for access to 'multimodal data' | GSK has been aggressively looking at AI, and in its newest venture, the Big Pharma has expanded a deal with an old partner in a bid to add to its capabilities.
The UK pharma put out word in the wee hours of Tuesday morning t... |
| 09.08.2022 | Lumea Selects Tempus to Advance AI-Driven Digital Pathology Solutions | Lumea, a leader in integrated digital pathology, has chosen Tempus, a leader in artificial intelligence and precision medicine, to create AI-enabled solutions LEHI, UTAH, USA, August 9, 2022 /EINPresswire.com/ -- Lumea Inc, a leader in inte... |
| 02.06.2022 | Precision healthcare AI tools eyed by investors | Artificial intelligence and machine learning promise to transform healthcare across the board, but particularly through the use of precision medicine.
Precision medicine is often defined differently than the common phrase “personalized medi... |
| 20.05.2022 | Tempus Launches Psychiatric Real-World Data Collaboration | What You Should Know:
– Tempus, an $8B precision medicine company, announced the launch of a new psychiatric real-world data program to leverage real-world data to inform mental health treatment.
– Tempus N+ is a collaboration between provi... |
| 22.03.2022 | With gaming and blockchain as focal points, Serbian startup ecosystem attracts record levels of investments | Belgrade, Serbia ~
Company:
Last year was one of the most successful ones for the Serbian startup ecosystem as it managed to attract over €123M in investments – an increase of 600% year over year. This year, the country looks set to build u... |
| 21.03.2022 | Tempus Launches Pathology-Driven AI Platform | What You Should Know:
– Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens ... |
| 13.01.2022 | GSK Launches Accelerated Clinical Trial with Tempus | What You Should Know:
– Tempus and GlaxoSmithKline (GSK) announced an accelerated phase II study evaluating the efficacy and safety of niraparib, an oral, once daily PARP inhibitor, for patients with breast and pancreatic cancers. The study... |
| 09.09.2021 | Cedars-Sinai Cancer Launches ‘Molecular Twin’ Initiative for Precision Cancer Treatment | What You Should Know:
– Cedars-Sinai Cancer and Tempus, a provider of artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas o... |
| 18.05.2021 | The 24 billion-dollar startups to watch that are revolutionizing healthcare in 2021 | The Tempus lab. Tempus This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
The financial fallout of the coronavirus pandemic didn't dampen interest in healthcare startups.
Healthcare startups... |
| 24.03.2021 | FDA Grants Breakthrough Device Designation to Tempus’ Atrial Fibrillation ECG Analysis Platform, Developed in Collaboration With Geisinger | CHICAGO--(BUSINESS WIRE)--Mar 24, 2021--
Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ... |
| 04.02.2021 | How Data And AI Will Continue To Change Healthcare In 2021 | General Partner & CEO at Pegasus Tech Ventures | Chairman of Startup World Cup. |
| 31.12.2020 | The top 12 VC funding rounds raised by Chicago startups in 2020 | Despite the economic challenges presented over the course of the Covid-19 pandemic in 2020, Chicago startups were still raising venture capital.
While the year's total venture numbers are still being tallied, Inno wanted to bring you the to... |
| 10.12.2020 | Google joins $200M round for Tempus, now valued at $8B | Cancer treatment startup Tempus has raised another mega-round of venture capital funding as it continues to grow as Chicago’s most valuable startup.
Tempus raised $200 million in a Series G-2 financing round that included Google, a first-ti... |
| 10.12.2020 | Tempus Labs, Inc. announced that it has received $200 million in funding from Franklin Resources, Inc., Alphabet Inc., Novo Holdings A/S, T. Rowe Price Associates, Inc., Baillie Gifford & Co., and... | On December 10, 2020, Tempus Labs, Inc. closed the transaction. The company has received $200,000,000 in the transaction. The transaction involved participation from returning investors, Franklin Resources, Inc. (NYSE:BEN), Novo Holdings A/... |
| 14.08.2020 | Top 5 Chicago Healthcare Companies Transforming Wellness | getty |
| 17.06.2020 | Precision medicine startup Tempus announces expansion into infectious diseases, starting with fight against COVID-19 | Tempus is a Chicago, IL-based health technology startup advancing precision medicine through the practical application of artificial intelligence in healthcare. The company was founded in 2015 by Groupon co-founder Eric Lefkofsky. Tempus co... |
| 01.04.2020 | Chicago Tech Raised At Least $218M in March | This is our roundup of Chicago tech and startup companies that received venture capital investments during the last month. If we missed one, let us know at info@chicagoinno.com.
To get funding updates in your inbox each day, sign up for the... |
| 16.03.2020 | Chicago-Based Tempus Raises $100M At $5B Valuation For AI-Driven Healthcare | 17 Shares Email Facebook Twitter LinkedIn
Tempus, a healthtech company started by Groupon co-founder Eric Lefkofsky, has raised a $100 million Series G round at a post-money valuation of $5 billion. The money comes less than 10 months after... |
| 16.03.2020 | Chicago-Based Tempus Raises $100M At $5B Valuation For AI-Driven Healthcare | 18 Shares Email Facebook Twitter LinkedIn
Tempus, a healthtech company started by Groupon co-founder Eric Lefkofsky, has raised a $100 million Series G round at a post-money valuation of $5 billion. The money comes less than 10 months after... |
| 16.03.2020 | Tempus Raises $100M in Series G Financing | Tempus, a Chicago, IL-based technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, raised an additional $100m in Series G financing at a post-money valuation of $5 billion... |
| 12.12.2019 | CVS Health Launches Transform Oncology Care Program, Partners with Tempus | – CVS Health launches Transform Oncology Care, which includes a comprehensive, first-of-its-kind precision medicine approach to oncology management for payors in collaboration with Tempus.
– Transform Oncology Care includes an innovative pr... |
| 11.11.2019 | Investors just poured more than $1 billion into startups using AI to tackle every part of healthcare. Here are the 5 healthcare AI startups raking in the most cash. | Dr. Ali Parsa, the CEO of Babylon Health. Jack Lewis Williams for Tailor Made London This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
The deal count for VC-backed healthcare deals is on pa... |
| 04.09.2019 | Healthtech Sees Highest Valuations in Over Five Years, Reveals Hampleton Partners’ Report | Sector sees highest median multiples on record and $8.3 billion in disclosed transaction value
M&A and PE investment focusing on disease prevention, patient experience and precision healthcare management software
Healthtech fundraising ... |
| 12.08.2019 | How Livongo Just Opened the Floodgate to a Digital Healthcare Wave | In the future, when we analyze moments in time when true innovation transformed an industry, we’ll remember an event that happened just a couple of weeks ago: Livongo’sIPO. By the end of its trading debut — which left the company valued at ... |
| 19.07.2019 | Some of the top precision health startups funded in 2019 | The precision medicine space is expected to grow to over $216.75 billion by 2028
Precision health, which is medicine that is tailored to each individual person, using their genes to figure out what treatments will work best for that individ... |
| 31.05.2019 | Groupon co-founder Eric Lefkofsky just raised another $200 million for his newest company, Tempus | When serial entrepreneur Eric Lefkofsky grows a company, he puts the pedal to the metal. When in 2011 his last company, the Chicago-based coupons site Groupon, raised $950 million from investors, it was the largest amount raised by a startu... |
| 30.05.2019 | Data-Driven Precision Medicine Startup Tempus Lands $200M to Expand Into New Therapeutic Areas | Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 billion dollars. The investors include Ba... |
| 30.05.2019 | Chicago Tech Companies Raised Nearly $275M in May | This is our roundup of Chicago tech and startup companies that received venture capital investments during the month of May. If we missed one, let us know at info@chicagoinno.com.
To get funding updates in your inbox each day, sign up for t... |
| 30.05.2019 | Cancer-Fighting Startup Tempus Raises $200M at a $3B Valuation | Eric Lefkofsky's genomic-sequencing startup Tempus has raised another massive round of funding as it brings its cancer-fighting tech to new therapeutic areas.
Tempus announced Thursday that it raised $200 million in a Series F round that va... |
| 26.04.2019 | Роботаблетки, карманное УЗИ, синтетические микробы, лекарство от старости и ещё 21 перспективная разработка медстартапов Статьи редакции... | Как изменится медицина в ближайшем будущем.
10 10 комментариев
14 649 просмотров
Слушать
По данным PitchBook, медицинские стартапы привлекли более $28,7 млрд за 2018 год. В подборке — «единороги-революционеры», которые не только привлекли м... |
